Institutional Ownership
Alnylam Pharmaceuticals Inc
CUSIP 02043QAB3NOTE 1.000% 9/1ALNYQ1 2026
Institutional Holders
9
13F filers
Shares Held
14.47M
Aggregate institutional
Institutional Value
$60.98M
Q1 2026
Net New Holders
-2
2 new · 4 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions2
Increased2
Decreased2
Sold out4
Institutional Holders
9 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Boussard & Gavaudan Investment Management LLP | 32.0K | $40.81M | +11.0K | Added |
| 2 | Bnp Paribas Asset Management Holding S.A. | 9.75M | $12.56M | +5.00M | Added |
| 3 | Ssi Investment Management LLC | 4.10M | $5.25M | +4.10M | New |
| 4 | Loomis Sayles & Co L P | 4.9K | $1.61M | −4.2K | Reduced |
| 5 | Sei Investments Co | 251.0K | $321.7K | 0 | Held |
| 6 | Bank Of New York Mellon Corp | 215.0K | $276.7K | +215.0K | New |
| 7 | Oppenheimer Asset Management Inc. | 81.0K | $103.8K | −1.0K | Reduced |
| 8 | Stephens Inc /Ar/ | 24.0K | $30.8K | 0 | Held |
| 9 | Mml Investors Services, LLC | 10.0K | $12.8K | 0 | Held |